Dendritic cell biology and its role in tumor immunotherapy
Y Wang, Y **ang, VW **n, XW Wang, XC Peng… - Journal of hematology & …, 2020 - Springer
As crucial antigen presenting cells, dendritic cells (DCs) play a vital role in tumor
immunotherapy. Taking into account the many recent advances in DC biology, we discuss …
immunotherapy. Taking into account the many recent advances in DC biology, we discuss …
The neonatal Fc receptor (FcRn): a misnomer?
Antibodies are essential components of an adaptive immune response. Immunoglobulin G
(IgG) is the most common type of antibody found in circulation and extracellular fluids …
(IgG) is the most common type of antibody found in circulation and extracellular fluids …
Albumin-based drug delivery: harnessing nature to cure disease
MT Larsen, M Kuhlmann, ML Hvam… - Molecular and cellular …, 2016 - Springer
The effectiveness of a drug is dependent on accumulation at the site of action at therapeutic
levels, however, challenges such as rapid renal clearance, degradation or non-specific …
levels, however, challenges such as rapid renal clearance, degradation or non-specific …
Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics
KMK Sand, M Bern, J Nilsen, HT Noordzij… - Frontiers in …, 2015 - frontiersin.org
The neonatal Fc receptor (FcRn) was first found to be responsible for transporting antibodies
of the immunoglobulin G (IgG) class from the mother to the fetus or neonate as well as for …
of the immunoglobulin G (IgG) class from the mother to the fetus or neonate as well as for …
Half-life extended biotherapeutics
RE Kontermann - Expert opinion on biological therapy, 2016 - Taylor & Francis
Introduction: Many of the biotherapeutics approved or under development suffer from a short
half-life necessitating frequent applications in order to maintain a therapeutic concentration …
half-life necessitating frequent applications in order to maintain a therapeutic concentration …
Human serum albumin binders: a piggyback ride for long-acting therapeutics
Highlights•A variety of albumin-binding moieties (ABMs) have been developed for half-life
extension of short-lived drugs.•Various drugs can incorporate a selected ABM for in situ HSA …
extension of short-lived drugs.•Various drugs can incorporate a selected ABM for in situ HSA …
The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery
M Bern, KMK Sand, J Nilsen, I Sandlie… - Journal of Controlled …, 2015 - Elsevier
Albumin is the most abundant protein in blood and acts as a molecular taxi for a plethora of
small insoluble substances such as nutrients, hormones, metals and toxins. In addition, it …
small insoluble substances such as nutrients, hormones, metals and toxins. In addition, it …
Serum albumin for magnetic nanoparticles coating
AS Chubarov - Magnetochemistry, 2022 - mdpi.com
Magnetic nanoparticles (MNPs) have great potential in biochemistry and medical science. In
particular, iron oxide nanoparticles have demonstrated a promising effect in various …
particular, iron oxide nanoparticles have demonstrated a promising effect in various …
Albumin-based drug designs for pharmacokinetic modulation
D Pilati, KA Howard - Expert opinion on drug metabolism & …, 2020 - Taylor & Francis
Introduction A poor pharmacokinetic profile due to inadequate distribution and rapid renal
clearance limits site-specific target engagement and drug efficacy. The inherent properties of …
clearance limits site-specific target engagement and drug efficacy. The inherent properties of …
Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin
C Azevedo, J Nilsen, A Grevys, R Nunes… - Journal of Controlled …, 2020 - Elsevier
Oral delivery of biopharmaceuticals, as insulin, is hampered by rapid degradation and
inefficient absorption in the gastrointestinal tract (GIT). To solve this, a new class of …
inefficient absorption in the gastrointestinal tract (GIT). To solve this, a new class of …